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In conclusion, the studies by Huang and 
colleagues2 and Kobilka and colleagues8 con-
tribute to an increasingly clear picture of the 
molecular events that take place during GPCR 
activation and inhibition. Yet, future studies 
will be needed to define the conformational 
substates within the inactive and active con-
formation ensembles and to determine the 
role that receptor oligomerization may have in 
those ensembles.
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controlling G-protein activation remains an 
open question (Fig. 2a). Reconstitution in 
lipid nanodiscs has clearly demonstrated that 
a β2AR monomer is sufficient to activate a 
G protein in vitro19, but one could speculate 
that the assembly into dimers or larger oligo-
mers could regulate such activation. Consistent 
with this idea, FRET studies following recon-
stitution of the β2AR into a model lipid bilayer 
indicated that the receptor can form tetra mers 
that are stabilized upon binding of inverse 
agonist, whereas the addition of G proteins 
destabilizes the oligomer, thus indicating that 
the tetramer may represent an inactive form of 
the receptor20. Furthermore, both positive and 
negative allosteric modulation of ligand bind-
ing to various GPCRs have been attributed to 
dimerization13 (Fig. 2b).
From pseudo-ceRNAs to circ-ceRNAs: a tale of  
cross-talk and competition
Riccardo Taulli, Cristian Loretelli & Pier Paolo Pandolfi
RNA is believed to have been the first reservoir of genetic information, but despite its ancient history, RNA 
continues to fascinate and is only now beginning to be understood in its entire variety and communication modality. 
New discoveries include the pseudogene RNA network regulating PTEN transcription and translation and the 
identification of circular RNAs as a new class of competing endogenous RNA molecules that sequester microRNAs 
to suppress their function.
For decades, RNA was considered to be 
merely a ‘carrier’ of genetic information, but 
in the past 15 years unexpected discoveries in 
the epigenetic landscape, from microRNAs 
(miRNAs) to pseudogenes and the recently 
described long noncoding RNAs (lncRNAs), 
have completely revolutionized this simplis-
tic view. miRNAs are small RNA molecules of 
20–22 nucleo tides that post-transcriptionally 
negatively modulate the translation and sta-
bility of target RNA molecules containing 
miRNA-responsive elements (MREs) in their 
sequence1. LncRNAs and pseudogenes are 
longer and surprisingly more numerous than 
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protein-encoding genes and are extremely 
versatile in their mechanism of action2,3.
Although one miRNA can potentially regu-
late hundreds of different mRNAs (each one 
in turn containing several MREs) the major-
ity of these transcripts are actively expressed 
and translated, which supports the existence 
of several mechanisms that counteract miRNA 
regulation to achieve homeostasis. Probably the 
most ancestral and intuitive example among 
these regulatory mechanisms is the cross-talk 
and functional competition among different 
RNA molecules, as epitomized by the interplay 
between miRNAs and competing endogenous 
RNAs (ceRNAs)4 (described below).
Three recent papers have now shed light on 
an intertwined system of interaction between 
noncoding RNA molecules and mRNAs from 
protein-coding genes. Johnsson et al.5 have 
identified a pseudogene network able to 
regulate phosphatase and tensin homolog 
(PTEN) at both the transcriptional and 
the post-transcriptional level. The PTEN 
pseudogene (PTENpg1) locus encodes three 
different lncRNA molecules: two functional 
antisense RNAs (asRNAs) and one sense 
PTENpg1. PTENpg1 asRNAα acts in trans, 
localizes to the PTEN promoter and inhibits 
PTEN transcription by recruiting epigenetic 
repressor complexes, whereas PTENpg1 
asRNAβ, which is partially complementary 
to PTENpg1 sense, promotes stabilization 
of PTENpg1 sense by binding its 5′ end. 
PTENpg1 sense was previously shown to act 
as a ceRNA for PTEN6 through its ability to 
compete for several miRNAs that also target 
PTEN. Thereby, the stabilization of PTENpg1 
sense by PTENpg1 asRNAβ can regulate its 
ceRNA activity6 (Fig. 1a), perhaps in a tissue-
specific manner, which further highlights the 
regulatory activity on antisense and pseudo-
gene RNAs species.
Knowledge of the endogenous competition 
between noncoding RNAs recently expanded 
with the discovery of a new, highly prevalent 
class of conserved RNA molecules called circu-
lar RNAs (circRNAs or ciRS)7,8. The majority of 
circRNAs overlap with coding genes, often at the 
protein-coding portion of the mRNAs, and arise 
from circularized splicing of the reverse ends 
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motifs of noncoding RNAs are still lacking in 
contrast to those of protein-coding genes. Base 
pair complementarity, however, represents a 
general property of all RNA molecules. On this 
basis, we have previously proposed that RNA 
species can communicate with one another by 
using the MREs of miRNAs as letters of a new 
RNA language, whereby RNA species sharing 
the same subset of MREs can regulate their 
relative abundance by competing for miRNAs4 
(Fig. 2a). The direct ceRNA cross-talk between 
PTEN and PTENpg1 sense represents one such 
example. The new findings by Johnsson et al.5 
now add another layer to this regulatory cross-
talk whereby PTENpg1 asRNAβ actively con-
tributes to this ceRNA network by stabilizing 
PTENpg1 sense (Fig. 1a).
Intriguingly, circRNAs are now emerg-
ing as potent ceRNA molecules. CircRNAs 
are expressed in a tissue-specific manner, are 
stable and conserved and may have regulatory 
roles during differentiation and evolution. 
Hundreds of human genes express circRNA 
isoforms in amounts comparable to those of 
their linear counterparts. If we consider that 
the majority of these arise from coding gene 
(in head-to-tail manner) of one or more exons 
(Fig. 1b). The circRNA CDR1 as (also known as 
ciRS-7) is an extraordinary example of a com-
peting endogenous RNA species9,10 (Fig. 1b). 
This brain-enriched circRNA contains more 
than 70 miR-7 MREs and forms complexes with 
Argonaute (AGO) protein, the catalytic core of 
the RNA-induced silencing complex (RISC). 
CDR1 as (ciRS-7) is coexpressed with miR-7 
in the brain and is colocalized in the P bodies, 
which suggests that miR-7 compartmentalizes 
CDR1 as (ciRS-7) to this organelle9. Silencing 
of CDR1 as (ciRS-7) in HEK-293 cells results in 
downregulation of miR-7 target genes as well as 
other genes, whereas morpholino knockdown 
of miR-7 and ectopic expression of CDR1 as 
(ciRS-7) are both associated with morphologi-
cal defects in the midbrain9,10.
Astonishingly, it has become recently appar-
ent that ~80% or our genome is biochemically 
functional and 70% or more is actively tran-
scribed3. This indicates that the total number of 
noncoding RNA genes vastly outnumbers that 
of the coding genome, with pseudogenes and 
lncRNAs among the most numerous species. 
But algorithms able to predict functional 
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Figure 1  New RNA species counteract miRNA function. (a) PTENpg1 asRNAβ is partially 
complementary to the first exon of PTENpg1 sense and promotes its stabilization (purple arrows). 
Thereby, PTENpg1 sense increases PTEN-mRNA abundance (red arrows) by sequestering miRNAs 
that also target PTEN. (b) circRNA CDR1 as (ciRS-7) arises from head-to-tail splicing of its precursor. 
CircRNA CDR1 as (ciRS-7) contains ~70 MREs for miR-7 and increases the expression of miR-7 
target genes (black and blue arrows) by sequestering miR-7. CircRNA CDR1 as (ciRS-7) is under 
miR-671 regulation. miR-671 is almost perfectly complementary to CDR1 as (ciRS-7), and, although 
circularization protects from canonical nucleases, this is not sufficient to counteract AGO2 slicer 
activity in RISC. (c) circRNAs containing several distinct MREs can sequester different miRNA families 
and increase the expression of all genes (colored arrows) under miRNA regulation. MREs and miRNAs 
are indicated as color-coded circles and rectangles, respectively, on the RNA molecules.
exons8, we speculate that circRNAs contain-
ing MREs shared by their linear counterparts 
might enable and modulate ceRNA cross-talk 
and ceRNA networks by reducing miRNA 
pressure on protein-coding RNAs in a tissue- 
or cell-specific manner, hence acting as circ-
ceRNAs. As PTENpg1 sense enhances PTEN 
expression by miRNA sequestration, circRNAs 
arising from the protein-coding gene—or the 
pseudogene—could protect the mRNA through 
the same mechanism (Fig. 1c).
We do not know exactly the actual com-
peting capability of the majority of circRNAs 
and pseudogenes, but if they are evolution-
arily selected to protect their cognate cod-
ing mRNAs, they may represent a powerful 
weapon against excess miRNAs and hence 
enhance ceRNA cross-talk, which occurs 
in permissive molecular environments11 
(Fig. 2b). Memczac et al.10 and Hansen 
et al.9 have described CDR1 as (ciRS-7) as a 
hot spot for miR-7, but this circRNA is also 
a miR-671 target. CircRNAs can potentially 
include several different MREs and use 
them to ‘talk’ with many other genes in a 
combinatory manner. Importantly, different 
miRNAs can exert distinct effects on the same 
circRNA; whereas miR-7 titers away CDR1 
as (ciRS-7) and promotes its compartmen-
talization in the P bodies, miR-671 binding 
results in its degradation12. This implies that, 
beyond their intrinsic stability, the amount 
of each circRNA may be finely tuned by spe-
cific cellular mechanisms that are still largely 
unknown. Moreover, turnover and degrada-
tion of circRNAs and other ceRNAs could also 
play a key part in the regulation of the ceRNA 
language. For instance, the degradation of 
a circRNA loaded with multiple miRNAs 
would release the burden of bound miRNAs, 
with a deep impact on overall ceRNA activity, 
by affecting the translation of tens or even 
hundreds of ceRNA transcripts, perhaps in 
localized fashion10.
As the biogenesis of circRNAs remains 
largely unknown, this will become another area 
of intense investigation. Noncolinear splicing is 
probably one of the most reliable mechanisms 
for generating circRNAs; however whether this 
is actively regulated remains to be elucidated. 
The high conservation of circRNAs makes it 
possible to study their function in vivo dur-
ing development as well as in diseases such 
as cancer, and their stability (due to their cir-
cular form) makes the spread of their ceRNA 
activity throughout different tissues possible. 
CircRNAs could be easily collected from bodily 
fluids and might represent new biomarkers in 
diagnosis as well as in response to specific 
therapies. Conversely, ectopic injection of 
therapeutic circRNAs (able, for example, to 
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other potential ceRNA molecules with unfore-
seen biological impacts remain to be discov-
ered. In taking advantage of next-generation 
sequencing technologies and sophisticated 
algorithms, however, the challenge remains to 
determine the functional significance of all this 
information and decipher the complexity of the 
intertwined relationship between the coding 
and noncoding genome.
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ceRNA. Other circRNAs and pseudogenes 
could contain multiple subsets of MREs, and 
the recent discovery of thousands of aberrant 
chimeric transcripts in prostate cancer, associ-
ated not with DNA rearrangements but instead 
with noncanonical splicing13, suggests that 
counteract oncogenic miRNAs) could over-
come the problem of therapeutic delivery of 
small RNA molecules. Although we cannot rule 
out other mechanisms of action for circRNAs, 
it is worth noting that CDR1 as (ciRS-7), with 
more than 70 MREs, does behave as a potent 
Figure 2  circRNAs enhance ceRNAs cross-talk. (a) ceRNA1 and ceRNA2 regulate each other’s levels 
by competing for the same pool of miRNAs. However, ceRNAs are still under negative regulation by 
abundant miRNAs. (b) circRNAs sharing MREs in common with ceRNA1 and ceRNA2 sequester excess 
miRNAs and in turn enhance ceRNA cross-talk and abundance. Thereby, the intertwined network 
among miRNAs, circRNAs and ceRNAs regulates cellular homeostasis, whereas its dysregulation 
may contribute to diseases such as cancer and neurodegenerative disorders. MREs and miRNAs are 















A role for eIF4AII in microRNA–mediated mRNA 
silencing
Elisa Izaurralde
A recent study on the mechanism of microRNA–mediated gene silencing suggests that microRNA–induced silencing 
complexes inhibit ribosome scanning by recruiting the DEAD-box RNA helicase eIF4AII through an interaction with 
the NOT1 subunit of the CCR4–NOT deadenylase complex.
MicroRNAs (miRNAs) are a large family 
of endogenous noncoding RNAs that post- 
transcriptionally silence the expression of 
a wide variety of mRNA targets containing 
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complementary sequences1. To exert their 
regulatory functions, animal miRNAs 
associate with an Argonaute protein (AGO) 
and a GW182-family protein in effec-
tor complexes known as miRNA-induced 
silencing complexes (miRISCs). These 
complexes induce translational repression, 
deadenylation and the 5′-to-3′exonucleolytic 
decay of mRNA targets with partially 
complementary binding sites, which are 
widespread in animal cells1.
Despite a decade of work, the question of 
how miRNAs repress translation has remained 
unanswered, although increasing evidence has 
pointed to an inhibition of translation initia-
tion1. A recent study published in Science by 
Meijer et al.2 provides intriguing evidence that 
translational repression may be achieved by 
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